GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)

W.L. Gore & Associates

Status: Completed

Conditions: Peripheral Arterial Disease

Treatments: Device: GORE® VIABAHN® Endoprosthesis

Study type: Observational

Funder types: Industry

Identifiers

NCT04706273

JPS 16-03

Details and patient eligibility

About

This study will confirm device efficacy and safety in the clinical setting after the launch of the GORE® VIABAHN® Endoprosthesis for the treatment of symptomatic peripheral arterial disease in the superficial femoral arteries.

Enrollment: 321 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Symptomatic peripheral arterial disease in superficial femoral artery lesions

Trial design

321 participants in 1 patient group

GORE® VIABAHN® Endoprosthesis

Description:

Participants with symptomatic peripheral arterial disease in superficial femoral artery lesions.

Treatment:

Device: GORE® VIABAHN® Endoprosthesis